Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.2 was added, replacing the previous v3.3.1. No study details or page content appear to be affected.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded Local Institution - 316 and Revision v3.3.1 (2025-11-19); removed Rozaliya Rangelova, Site 316, and Lifemed recruitment contact (2025-11-04).SummaryDifference0.2%

- Check19 days agoChange DetectedAdded related topics 'Schizophrenia' and MedlinePlus Genetics; removed the government funding/status notice.SummaryDifference0.1%

- Check26 days agoChange DetectedTwo new Local Institutions (Site 110 and Site 148) were added with their contact numbers, and recruitment-related entries and dates were updated.SummaryDifference0.3%

- Check33 days agoChange DetectedAdded related topics: Schizophrenia and MedlinePlus Genetics to the page.SummaryDifference0.2%

- Check40 days agoChange DetectedThe related topics 'Schizophrenia' and 'MedlinePlus Genetics' were removed from the study page. This reduces disease-specific tagging and can affect how the trial is discovered and indexed for schizophrenia-related searches.SummaryDifference0.0%

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.